Literature DB >> 301025

Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families.

F C Arnett, B Z Schacter, M C Hochberg, S H Hsu, W B Bias.   

Abstract

The effect of homozygosity for HLA-B27 on the clinical expression of rheumatic disease was studied in two families. The 1 homozygous patient in each of two families demonstrated extraordinarily severe peripheral and axial arthritis compared to other affected heterozygous relatives. In addition, predominant peripheral or axial disease appeared to segregate with different B27 haplotypes. The 2 homozygous patients were not homozygous at the hla-a,c, or D loci.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301025     DOI: 10.1002/art.1780200306

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Animal models of the spondyloarthropathies.

Authors:  M Breban; G Falgarone; H Blanchard; E Dernis-Labous; D Lamarque
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

2.  Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis.

Authors:  M A Brown; S H Laval; S Brophy; A Calin
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Ankylosing Spondylitis: HLA-B*27-Positive Versus HLA-B*27-Negative Disease.

Authors:  Nurullah Akkoç; Handan Yarkan; Gökçe Kenar; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

4.  The relationship between genetics and environment in the pathogenesis of rheumatic diseases.

Authors:  A Calin
Journal:  West J Med       Date:  1979-09

5.  Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis.

Authors:  W P Maksymowych; M Suarez-Almazor; C T Chou; A S Russell
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.